Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Fortescue share price rises as FMG investors eye quarterly report and iron ore jitters

Fortescue share price rises as FMG investors eye quarterly report and iron ore jitters

Fortescue shares rose 1.7% to A$22.64, rebounding ahead of its December production report due Thursday. The ASX 200 slipped 0.4%, but materials gained 2.7% on miner strength. Iron ore futures fell after weak China property data, while a fatal blast at a Chinese steel plant raised supply concerns. BHP agreed to lower some iron ore prices in ongoing talks with China Mineral Resources Group.
21 January 2026
···
Why UMC stock is up 16% today: 8-inch price hike talk meets Taiwan’s CPO buzz

Why UMC stock is up 16% today: 8-inch price hike talk meets Taiwan’s CPO buzz

United Microelectronics Corp shares jumped 16% Tuesday, closing at $10.82 and leading semiconductor gains as U.S. markets fell. Taipei-listed UMC hit the daily limit before settling up 6-7%, fueled by rumors of 8-inch wafer price hikes. Foreign investors remained net buyers, and UMC confirmed its Singapore Fab 12i P3 expansion is moving toward mass production by 2027. Investors await UMC’s earnings report on Jan. 28.
20 January 2026
··
HYMC stock jumps nearly 17% as silver breaks $95 — what’s driving Hycroft Mining today

HYMC stock jumps nearly 17% as silver breaks $95 — what’s driving Hycroft Mining today

Hycroft Mining shares jumped 16.8% to $40.45 Tuesday as gold hit $4,700 an ounce and silver reached $95, both record highs. Canadian investor Eric Sprott exercised over 4.6 million warrants and bought 200,000 shares last week. Hycroft, which owns a large Nevada mine, has no current production and warned it needs more funding to advance development. Trading volume neared 3 million shares by midday.
20 January 2026
···
Qiagen stock price jumps nearly 16% as Bloomberg report revives sale talk

Qiagen stock price jumps nearly 16% as Bloomberg report revives sale talk

Qiagen shares jumped 15.9% to $55.13 in U.S. trading Tuesday after reports the diagnostics firm is exploring strategic options, including a potential sale, and has hired advisers. Bloomberg said the company’s board is handling new takeover interest, but talks remain preliminary. Qiagen will report fourth-quarter results Feb. 4, with a conference call set for Feb. 5. The company has not commented on the reports.
20 January 2026
··
MARA stock slides as CEO Thiel trust flags share sale while bitcoin dips

MARA stock slides as CEO Thiel trust flags share sale while bitcoin dips

MARA shares fell 5.1% to $10.78 by midday Tuesday after a filing showed CEO Fred Thiel’s trust intends to sell 27,505 shares under Rule 144. Bitcoin dropped 3%, pressuring mining stocks. The planned sale, valued at $297,054, follows similar trust sales in November and December. Traders are watching for a follow-up insider filing and bitcoin’s next move.
20 January 2026
···
AstraZeneca stock price slides as AZN sets Nasdaq exit, NYSE move dates

AstraZeneca stock price slides as AZN sets Nasdaq exit, NYSE move dates

AstraZeneca shares fell 4.4% to $90.23 Tuesday after the company said it will delist its American depositary shares from Nasdaq and move to a direct listing of ordinary shares on the NYSE starting February 2. The switch, set for after markets close January 30, comes as European stocks face pressure from U.S. tariff threats. AstraZeneca’s London shares also dropped 2.6%.
20 January 2026
···
Riot Platforms stock dips as bitcoin slides, even as Needham lifts target on AMD lease

Riot Platforms stock dips as bitcoin slides, even as Needham lifts target on AMD lease

Riot Platforms shares fell 2.8% to $18.70 Tuesday morning as bitcoin dropped 2.9% and crypto stocks sold off. Needham raised its price target on Riot to $30, citing a new 10-year data-center lease with AMD expected to generate $311 million in revenue. Riot recently bought land in Texas for $96 million, funded by selling 1,080 bitcoin. Investors remain cautious as Riot’s stock continues to track bitcoin’s moves.
20 January 2026
·····
Kenvue stock ticks up as investors size up Kimberly-Clark takeover vote in days

Kenvue stock ticks up as investors size up Kimberly-Clark takeover vote in days

Kenvue shares rose 0.6% to $17.31 in late-morning New York trading Tuesday as investors awaited a Jan. 29 shareholder vote on its proposed sale to Kimberly-Clark. The deal’s outcome remains uncertain amid ongoing litigation risks tied to Kenvue’s legacy products. ISS has backed the merger but flagged legal concerns. Kenvue’s virtual shareholder meeting is scheduled for 9:00 a.m. Eastern on Jan. 29.
20 January 2026
··
Revo Hospitality insolvency: 125 hotels stay open in Germany and Austria as operator seeks rescue

Revo Hospitality insolvency: 125 hotels stay open in Germany and Austria as operator seeks rescue

Revo Hospitality has filed for insolvency under self-administration in Berlin, impacting about 140 group companies and 125 hotels in Germany and Austria. The company says all hotels will remain open as restructuring continues through summer. Around 5,500 staff are affected. Rising wage costs and integration issues after rapid expansion were cited as reasons for the filing.
20 January 2026
1 … 135 136 137 138 139 … 535

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop